订阅小程序
旧版功能

ENGOT-EN20/GOG-3083/XPORT-EC-042 A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy after Systemic Therapy for Patients (pts) with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (1246)

Vicky Makker,Ignace Vergote,Mansoor Mirza,Robert Coleman,Jose Alejandro Perez Fidalgo,Bradley Monk,Giorgio Valabrega,Brian Slomovitz,Toon van Gorp, Kathleen Moore,Jalid Sehouli,David Cibula,Tally Levy,Gerasimos Aravantinos, Patricia Judson,Reshma Rangwala, Xulong Wang

Gynecologic Oncology（2023）

引用 0|浏览3
关键词
Hormone Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要